 
         
         Abstract
         
         
         
            
Background
            
            Venous thromboembolism (VTE) is a serious complication of pediatric acute lymphoblastic
               leukemia (ALL), primarily occurring during induction therapy and associated with acquired
               hemostatic abnormalities. However, the contribution of leukemic lymphoblasts to hypercoagulability
               remains unexplored. This study aimed to determine whether leukemic lymphoblasts express
               hemostatic factors that promote a hypercoagulable state and to assess the functional
               impact of lysed lymphoblasts on thrombin and fibrin generation.
            
         
         
            
Methods
            
            We examined the expression of 28 hemostatic factors at both mRNA and protein levels
               in four pediatric leukemic cell lines (T-ALL and B-ALL) and normal lymphocytes using
               RT-PCR and immunoblotting. To evaluate the overall functional effect, we conducted
               thrombin and fibrin generation assays by adding cell lysates to platelet-poor plasma
               in the absence of exogenous tissue factor or phospholipids.
            
         
         
            
Results
            
            Leukemic lymphoblasts constitutively expressed the procoagulants tissue factor, factor
               VIII and factor XIIIa; the coagulation inhibitors antithrombin, ADAMTS13 and TFPI;
               and the pro-fibrinolytic and antifibrinolytic proteins uPA, TAFI, and α2-AP. Lysed,
               but not intact, leukemic lymphoblasts enhanced thrombin and fibrin generation, indicating
               a procoagulant state. Additionally, leukemic lysates exhibited a hypo-fibrinolytic
               state, as evidenced by prolonged fibrin clot lysis times.
            
         
         
            
Conclusion
            
            These findings suggest that leukemic lymphoblasts actively contribute to a hypercoagulable
               state in pediatric ALL by simultaneously increasing procoagulant activity and impairing
               fibrinolysis. This study provides novel insights into the mechanisms underlying VTE
               risk in pediatric ALL, highlighting the role of leukemic lymphoblasts in disrupting
               the hemostatic balance.
            
         
         
            
Key Points
            
            
               
               - 
                  
                  Leukemic lymphoblasts express hemostatic system factors at gene and protein levels. 
- 
                  
                  Leukemic lymphoblasts lysis directly contributes to hypercoagulability and hypofibrinolysis
                     in thrombin and fibrin generation assays. 
Keywords
venous thrombosis - hypercoagulability - pediatric acute lymphoblastic leukemia -
            hypofibrinolysis